Please use this identifier to cite or link to this item:
|Title:||The potential of secondary metabolites from plants as drugs or leads against protozoan neglected diseases - Part I|
|Authors:||Schmidt, Thomas Jürgen|
Khalid, Sami A.
Romanha, Álvaro José
Alves, Tânia Maria de Almeida
Biavatti, Maique Weber
Costa, Fernando Batista da
De-Castro, Solange Lisboa
Ferreira, V?tor Francisco
Lacerda, Marcus Vinícius Guimarães de
Lago, João Henriqu Ghilardi
Leon, Leonor Laura Pinto
Lopes, Norberto Peporine
Amorim, Rodrigo César das Neves
Ogungbe, Ifedayo Victor
Pohlit, Adrian Martin
Scotti, M. T.
Setzer, William N.
Soeiro, M. N.C. de
Steindel, Mário R.
Tempone, Andre Gustavo
|Keywords:||Ageratum Conyzoides Extract|
Phase 1 Clinical Trial (topic)
Phase 2 Clinical Trial (topic)
Phase 3 Clinical Trial (topic)
World Health Organization
|metadata.dc.publisher.journal:||Current Medicinal Chemistry|
|metadata.dc.relation.ispartof:||Volume 19, Número 14, Pags. 2128-2175|
|Abstract:||Infections with protozoan parasites are a major cause of disease and mortality in many tropical countries of the world. Diseases caused by species of the genera Trypanosoma (Human African Trypanosomiasis and Chagas Disease) and Leishmania (various forms of Leishmaniasis) are among the seventeen "Neglected Tropical Diseases" (NTDs) defined as such by WHO due to the neglect of financial investment into research and development of new drugs by a large part of pharmaceutical industry and neglect of public awareness in high income countries. Another major tropical protozoan disease is malaria (caused by various Plasmodium species), which -although not mentioned currently by the WHO as a neglected disease- still represents a major problem, especially to people living under poor circumstances in tropical countries. Malaria causes by far the highest number of deaths of all protozoan infections and is often (as in this review) included in the NTDs. The mentioned diseases threaten many millions of lives world-wide and they are mostly associated with poor socioeconomic and hygienic environment. Existing therapies suffer from various shortcomings, namely, a high degree of toxicity and unwanted effects, lack of availability and/or problematic application under the life conditions of affected populations. Development of new, safe and affordable drugs is therefore an urgent need. Nature has provided an innumerable number of drugs for the treatment of many serious diseases. Among the natural sources for new bioactive chemicals, plants are still predominant. Their secondary metabolism yields an immeasurable wealth of chemical structures which has been and will continue to be a source of new drugs, directly in their native form and after optimization by synthetic medicinal chemistry. The current review, published in two parts, attempts to give an overview on the potential of such plant-derived natural products as antiprotozoal leads and/or drugs in the fight against NTDs. © 2012 Bentham Science Publishers.|
|Appears in Collections:||Artigos|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.